CDC Recommendations on Managing Homebirth When Intrapartum Antibiotics Are Refused

Effectiveness of Intrapartum Antibiotic Prophylaxis

In pregnant women colonized with Streptococcus agalactiae (GBS), administering intravenous antibiotics at least 4 hours before delivery reduces early‑onset neonatal GBS disease by 78‑89 % compared with no prophylaxis, making it one of the most effective obstetric preventive measures. 1
The protective effect of prophylaxis is time‑dependent; a minimum interval of 4 hours before birth provides maximal benefit, although shorter exposure still confers partial protection. 1

The patient’s GBS status must be recorded (positive culture at 36‑37 weeks, documented GBS bacteriuria at any concentration, or unknown status with risk factors) in the medical record. 1
A detailed discussion with the patient must include the 78‑89 % risk reduction with prophylaxis, the ≈ 29‑fold increased neonatal disease risk without it, and the potential sequelae (sepsis, pneumonia, meningitis, death); this discussion must be documented. 1
The clinician must explicitly note that intrapartum intravenous antibiotics are the only effective strategy—oral antibiotics given before labor do not eradicate colonization nor prevent neonatal disease. 1
The patient must sign an informed‑refusal form that outlines the specific risks and confirms her understanding of the information provided. 1

Any episode of GBS bacteriuria at any concentration during the current pregnancy automatically qualifies the mother for intrapartum prophylaxis because it reflects heavy colonization and a higher transmission risk. 1
A prior infant with invasive GBS disease identifies the mother as high‑risk and mandates prophylaxis in subsequent pregnancies. 1
Additional obstetric conditions—preterm labor (< 37 weeks), prolonged rupture of membranes (≥ 18 hours), or intrapartum fever (≥ 38.0 °C)—each substantially increase the likelihood of early‑onset neonatal GBS disease and therefore warrant prophylaxis. 1
When GBS status is unknown at term but any of the above risk factors are present, empiric intrapartum prophylaxis is indicated; refusal in this context represents a particularly high neonatal risk. 1

Women undergoing a planned cesarean delivery before labor onset with intact membranes do not require routine intrapartum GBS prophylaxis; however, this exemption does not apply to homebirths where labor and membrane rupture are expected. 2

Limiting the number of vaginal examinations during labor can reduce the introduction of bacteria into the upper genital tract, though it does not replace the need for intrapartum antibiotics. 2
Avoiding artificial rupture of membranes unless medically indicated helps prevent prolonged exposure of the fetus to vaginal flora, thereby lowering infection risk. 1
Maintaining strict hygiene practices throughout delivery (hand hygiene, clean delivery environment) is recommended, but these measures alone cannot prevent vertical transmission of GBS already present in the birth canal. 1

The discussion about the benefits and risks of intrapartum antibiotics should be revisited at multiple prenatal visits, allowing the patient the opportunity to reconsider her decision as delivery approaches. 1
Clinicians should proactively address patient concerns regarding antibiotic allergies, side‑effects, and resistance by providing evidence‑based information, thereby supporting informed decision‑making. 1

The Centers for Disease Control and Prevention recommends intravenous antibiotics during labor for women with positive GBS screening culture at 36-37 weeks' gestation, GBS bacteriuria at any concentration during the current pregnancy, previous infant with invasive GBS disease, unknown GBS status at term with membrane rupture >18 hours, or preterm labor or rupture of membranes with unknown or positive GBS status 3, 4, 5
The American College of Obstetricians and Gynecologists indicates that women undergoing planned cesarean delivery before labor onset with intact membranes do not require routine GBS prophylaxis, regardless of colonization status 6

The Centers for Disease Control and Prevention recommends penicillin G as the first-line therapy, with a dose of 5 million units IV initially, then 2.5 million units IV every 4 hours until delivery, due to its narrower antimicrobial spectrum 7
For penicillin-allergic patients, cefazolin, clindamycin, or vancomycin may be used as alternative therapies, with specific dosing regimens 4, 7

The Centers for Disease Control and Prevention recommends that antibiotics be administered at least 4 hours before delivery to achieve optimal prevention of vertical GBS transmission and early-onset neonatal disease 7, 8

Intrapartum antibiotic prophylaxis reduces early-onset GBS disease by 86-89% when administered appropriately, according to the Centers for Disease Control and Prevention 7

For women with threatened preterm delivery, the Centers for Disease Control and Prevention recommends initiating GBS prophylaxis immediately while obtaining vaginal-rectal cultures, then continuing if true labor progresses or discontinuing if labor is successfully arrested 3, 5